 | • レポートコード：MRC309Z7992 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の注射用テルリプレシンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の注射用テルリプレシン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 注射用テルリプレシンの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 注射用テルリプレシン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・塊状、粉末状 用途別セグメント ・内科、外科、集中治療室（ICU） 主要な市場プレーヤー ・Ferring Pharmaceuticals、Ranbaxy UK Ltd、TAJ LIFE SCIENCES、Mallinckrodt plc、EVER Pharma、Alliance Pharmaceuticals、Serum Institute of India Pvt. Ltd、Biovenice Criticure、Criticine Care、Integrated Laboratories Pvt Ltd、Hybio Pharmaceutical Co., Ltd、Fujian Mindong Rejuenation Pharmaceutical Co., Ltd、Hangzhou Ausia Biological Technology Company, Ltd、Nanjing Kangzhou Pharmaceutical Technology Co., Ltd、Hainan General Sanyang Pharmaceutical Co., Ltd 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、注射用テルリプレシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な注射用テルリプレシンメーカーの企業概要、2019年～2022年までの注射用テルリプレシンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な注射用テルリプレシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別注射用テルリプレシンの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの注射用テルリプレシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での注射用テルリプレシン市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および注射用テルリプレシンの産業チェーンを掲載しています。 ・第14、15章では、注射用テルリプレシンの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 注射用テルリプレシンの概要 - 種類別分析（2018年vs2022年vs2029年）：塊状、粉末状 - 用途別分析（2018年vs2022年vs2029年）：内科、外科、集中治療室（ICU） - 世界の注射用テルリプレシン市場規模・予測 - 世界の注射用テルリプレシン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Ferring Pharmaceuticals、Ranbaxy UK Ltd、TAJ LIFE SCIENCES、Mallinckrodt plc、EVER Pharma、Alliance Pharmaceuticals、Serum Institute of India Pvt. Ltd、Biovenice Criticure、Criticine Care、Integrated Laboratories Pvt Ltd、Hybio Pharmaceutical Co., Ltd、Fujian Mindong Rejuenation Pharmaceutical Co., Ltd、Hangzhou Ausia Biological Technology Company, Ltd、Nanjing Kangzhou Pharmaceutical Technology Co., Ltd、Hainan General Sanyang Pharmaceutical Co., Ltd ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：塊状、粉末状 ・用途別分析2018年-2029年：内科、外科、集中治療室（ICU） ・注射用テルリプレシンの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・注射用テルリプレシンのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・注射用テルリプレシンのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・注射用テルリプレシンの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・注射用テルリプレシンの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Terlipressin for Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Terlipressin for injection is a synthetic polypeptide that is an analog of the hormone secreted by the posterior pituitary gland. After injection, its triglycyl group will be cleaved by enzymes in the body to slowly release active substances such as vasopressin, which can contract smooth muscles and last for 10 hours. Vasopressin mainly has two effects: one is the obvious vasoconstriction effect, thereby reducing the venous blood flow to the hepatic portal system, thereby lowering the portal blood pressure and having a hemostatic effect; Body, prevent excessive loss of water in urine, has anti-enuresis function. Terlipressin for injection lowers HVPG faster, stronger, and longer, and it is a drug for the treatment of complications of portal hypertension.
This report is a detailed and comprehensive analysis for global Terlipressin for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Terlipressin for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Terlipressin for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Terlipressin for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Terlipressin for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Terlipressin for Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Terlipressin for Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ferring Pharmaceuticals, Ranbaxy UK Ltd, TAJ LIFE SCIENCES, Mallinckrodt plc and EVER Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Terlipressin for Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Lumps
Powder
Market segment by Application
Internal Medicine Application
surgical application
Intensive Care Unit (ICU) Applications
Major players covered
Ferring Pharmaceuticals
Ranbaxy UK Ltd
TAJ LIFE SCIENCES
Mallinckrodt plc
EVER Pharma
Alliance Pharmaceuticals
Serum Institute of India Pvt. Ltd
Biovenice Criticure
Criticine Care
Integrated Laboratories Pvt Ltd
Hybio Pharmaceutical Co., Ltd
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd
Hangzhou Ausia Biological Technology Company, Ltd
Nanjing Kangzhou Pharmaceutical Technology Co., Ltd
Hainan General Sanyang Pharmaceutical Co., Ltd
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Terlipressin for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Terlipressin for Injection, with price, sales, revenue and global market share of Terlipressin for Injection from 2018 to 2023.
Chapter 3, the Terlipressin for Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Terlipressin for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Terlipressin for Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Terlipressin for Injection.
Chapter 14 and 15, to describe Terlipressin for Injection sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Terlipressin for Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Terlipressin for Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Lumps
1.3.3 Powder
1.4 Market Analysis by Application
1.4.1 Overview: Global Terlipressin for Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Internal Medicine Application
1.4.3 surgical application
1.4.4 Intensive Care Unit (ICU) Applications
1.5 Global Terlipressin for Injection Market Size & Forecast
1.5.1 Global Terlipressin for Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Terlipressin for Injection Sales Quantity (2018-2029)
1.5.3 Global Terlipressin for Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Ferring Pharmaceuticals
2.1.1 Ferring Pharmaceuticals Details
2.1.2 Ferring Pharmaceuticals Major Business
2.1.3 Ferring Pharmaceuticals Terlipressin for Injection Product and Services
2.1.4 Ferring Pharmaceuticals Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Ferring Pharmaceuticals Recent Developments/Updates
2.2 Ranbaxy UK Ltd
2.2.1 Ranbaxy UK Ltd Details
2.2.2 Ranbaxy UK Ltd Major Business
2.2.3 Ranbaxy UK Ltd Terlipressin for Injection Product and Services
2.2.4 Ranbaxy UK Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ranbaxy UK Ltd Recent Developments/Updates
2.3 TAJ LIFE SCIENCES
2.3.1 TAJ LIFE SCIENCES Details
2.3.2 TAJ LIFE SCIENCES Major Business
2.3.3 TAJ LIFE SCIENCES Terlipressin for Injection Product and Services
2.3.4 TAJ LIFE SCIENCES Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 TAJ LIFE SCIENCES Recent Developments/Updates
2.4 Mallinckrodt plc
2.4.1 Mallinckrodt plc Details
2.4.2 Mallinckrodt plc Major Business
2.4.3 Mallinckrodt plc Terlipressin for Injection Product and Services
2.4.4 Mallinckrodt plc Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mallinckrodt plc Recent Developments/Updates
2.5 EVER Pharma
2.5.1 EVER Pharma Details
2.5.2 EVER Pharma Major Business
2.5.3 EVER Pharma Terlipressin for Injection Product and Services
2.5.4 EVER Pharma Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 EVER Pharma Recent Developments/Updates
2.6 Alliance Pharmaceuticals
2.6.1 Alliance Pharmaceuticals Details
2.6.2 Alliance Pharmaceuticals Major Business
2.6.3 Alliance Pharmaceuticals Terlipressin for Injection Product and Services
2.6.4 Alliance Pharmaceuticals Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Alliance Pharmaceuticals Recent Developments/Updates
2.7 Serum Institute of India Pvt. Ltd
2.7.1 Serum Institute of India Pvt. Ltd Details
2.7.2 Serum Institute of India Pvt. Ltd Major Business
2.7.3 Serum Institute of India Pvt. Ltd Terlipressin for Injection Product and Services
2.7.4 Serum Institute of India Pvt. Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Serum Institute of India Pvt. Ltd Recent Developments/Updates
2.8 Biovenice Criticure
2.8.1 Biovenice Criticure Details
2.8.2 Biovenice Criticure Major Business
2.8.3 Biovenice Criticure Terlipressin for Injection Product and Services
2.8.4 Biovenice Criticure Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biovenice Criticure Recent Developments/Updates
2.9 Criticine Care
2.9.1 Criticine Care Details
2.9.2 Criticine Care Major Business
2.9.3 Criticine Care Terlipressin for Injection Product and Services
2.9.4 Criticine Care Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Criticine Care Recent Developments/Updates
2.10 Integrated Laboratories Pvt Ltd
2.10.1 Integrated Laboratories Pvt Ltd Details
2.10.2 Integrated Laboratories Pvt Ltd Major Business
2.10.3 Integrated Laboratories Pvt Ltd Terlipressin for Injection Product and Services
2.10.4 Integrated Laboratories Pvt Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Integrated Laboratories Pvt Ltd Recent Developments/Updates
2.11 Hybio Pharmaceutical Co., Ltd
2.11.1 Hybio Pharmaceutical Co., Ltd Details
2.11.2 Hybio Pharmaceutical Co., Ltd Major Business
2.11.3 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Product and Services
2.11.4 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hybio Pharmaceutical Co., Ltd Recent Developments/Updates
2.12 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd
2.12.1 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Details
2.12.2 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Major Business
2.12.3 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Product and Services
2.12.4 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Recent Developments/Updates
2.13 Hangzhou Ausia Biological Technology Company, Ltd
2.13.1 Hangzhou Ausia Biological Technology Company, Ltd Details
2.13.2 Hangzhou Ausia Biological Technology Company, Ltd Major Business
2.13.3 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Product and Services
2.13.4 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hangzhou Ausia Biological Technology Company, Ltd Recent Developments/Updates
2.14 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd
2.14.1 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Details
2.14.2 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Major Business
2.14.3 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Product and Services
2.14.4 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Recent Developments/Updates
2.15 Hainan General Sanyang Pharmaceutical Co., Ltd
2.15.1 Hainan General Sanyang Pharmaceutical Co., Ltd Details
2.15.2 Hainan General Sanyang Pharmaceutical Co., Ltd Major Business
2.15.3 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Product and Services
2.15.4 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Hainan General Sanyang Pharmaceutical Co., Ltd Recent Developments/Updates
3 Competitive Environment: Terlipressin for Injection by Manufacturer
3.1 Global Terlipressin for Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Terlipressin for Injection Revenue by Manufacturer (2018-2023)
3.3 Global Terlipressin for Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Terlipressin for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Terlipressin for Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Terlipressin for Injection Manufacturer Market Share in 2022
3.5 Terlipressin for Injection Market: Overall Company Footprint Analysis
3.5.1 Terlipressin for Injection Market: Region Footprint
3.5.2 Terlipressin for Injection Market: Company Product Type Footprint
3.5.3 Terlipressin for Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Terlipressin for Injection Market Size by Region
4.1.1 Global Terlipressin for Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Terlipressin for Injection Consumption Value by Region (2018-2029)
4.1.3 Global Terlipressin for Injection Average Price by Region (2018-2029)
4.2 North America Terlipressin for Injection Consumption Value (2018-2029)
4.3 Europe Terlipressin for Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Terlipressin for Injection Consumption Value (2018-2029)
4.5 South America Terlipressin for Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Terlipressin for Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Terlipressin for Injection Sales Quantity by Type (2018-2029)
5.2 Global Terlipressin for Injection Consumption Value by Type (2018-2029)
5.3 Global Terlipressin for Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Terlipressin for Injection Sales Quantity by Application (2018-2029)
6.2 Global Terlipressin for Injection Consumption Value by Application (2018-2029)
6.3 Global Terlipressin for Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Terlipressin for Injection Sales Quantity by Type (2018-2029)
7.2 North America Terlipressin for Injection Sales Quantity by Application (2018-2029)
7.3 North America Terlipressin for Injection Market Size by Country
7.3.1 North America Terlipressin for Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Terlipressin for Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Terlipressin for Injection Sales Quantity by Type (2018-2029)
8.2 Europe Terlipressin for Injection Sales Quantity by Application (2018-2029)
8.3 Europe Terlipressin for Injection Market Size by Country
8.3.1 Europe Terlipressin for Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Terlipressin for Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Terlipressin for Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Terlipressin for Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Terlipressin for Injection Market Size by Region
9.3.1 Asia-Pacific Terlipressin for Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Terlipressin for Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Terlipressin for Injection Sales Quantity by Type (2018-2029)
10.2 South America Terlipressin for Injection Sales Quantity by Application (2018-2029)
10.3 South America Terlipressin for Injection Market Size by Country
10.3.1 South America Terlipressin for Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Terlipressin for Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Terlipressin for Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Terlipressin for Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Terlipressin for Injection Market Size by Country
11.3.1 Middle East & Africa Terlipressin for Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Terlipressin for Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Terlipressin for Injection Market Drivers
12.2 Terlipressin for Injection Market Restraints
12.3 Terlipressin for Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Terlipressin for Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Terlipressin for Injection
13.3 Terlipressin for Injection Production Process
13.4 Terlipressin for Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Terlipressin for Injection Typical Distributors
14.3 Terlipressin for Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer